Treatment of hemolytic disease of the newborn caused by anti-kell antibody with recombinant erythropoietin

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 1, 2001, Pages 69-70

  Dhodapkar, Kavita M ^a   Blei, Francine ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Erythropoietin; Hemolysis; Kell

Indexed keywords

BILIRUBIN; BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; IRON; RECOMBINANT ERYTHROPOIETIN;

ALLOIMMUNITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; DRUG INDICATION; FEMALE; HEMATOCRIT; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; INFANT; IRON THERAPY; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; PRIORITY JOURNAL; RETICULOCYTE COUNT; SYMPTOM;

ADULT; AUTOANTIBODIES; ERYTHROBLASTOSIS, FETAL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; INFANT, PREMATURE; KELL BLOOD-GROUP SYSTEM; PHOTOTHERAPY; PREGNANCY;

EID: 0035153604     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200101000-00018     Document Type: Article

References (9)

1. Marsh WL, Redman CM. The Kell blood group system: A review. Transfusion 1990; 30:158-67.
2. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174:547-51.
3. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NN. Erythropoietic suppression in fetal anemia because of Kell alloimunization. Am J Obstet Gynecol 1994; 171:247-52.
4. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338:798-803.
5. Millard DD, Gidding SS, Socol M, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990; 117:447-54.
6. Lee S, Zambas ED, Marsh WL, Redman CM. The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 1993; 81:2804-09.
7. Southcott M, Tanner M, Anstee D. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999; 93:4425-35.
8. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by kell blood group protein. Blood 1999; 94:1440-50.
9. Ovali F, Samanci N, Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996; 39:831-4.